Claro Advisors LLC reduced its holdings in ARK Genomic Revolution ETF (BATS:ARKG) by 7.8% during the first quarter, according to a recent filing with the SEC. The fund owned 7,228 shares of the company’s stock after selling 609 shares, with holdings valued at $208,000. Other large investors have also made changes to their positions in ARKG, with new stakes ranging from $32,000 to $66,000.
ARK Genomic Revolution ETF opened at $22.89 on Wednesday, with a fifty day moving average price of $24.97 and a 200 day moving average price of $27.96. The fund, launched on Oct 31, 2014 and managed by ARK, mostly invests in stocks related to the genomics industry.
Interested in seeing what other hedge funds are holding ARKG? Visit HoldingsChannel.com for the latest filings and insider trades for ARK Genomic Revolution ETF. Subscribe to receive daily news and ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com’s free email newsletter.